Immune Spatial Features of Guselkumab Cutaneous Response

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Psoriasis of Scalp

Interventions

DRUG

Guselkumab

Guselkumab treatment for \~ 9 months

Trial Locations (1)

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

lead

University of California, San Francisco

OTHER